These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 32860528)

  • 1. The pharmacological effects of inhaled cannabis on pain in patients with multiple sclerosis: risks versus rewards.
    Maayah ZH; Dyck JRB
    Inflamm Res; 2020 Nov; 69(11):1073-1076. PubMed ID: 32860528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Systematic review of safeness and therapeutic efficacy of cannabis in patients with multiple sclerosis, neuropathic pain, and in oncological patients treated with chemotherapy].
    Amato L; Minozzi S; Mitrova Z; Parmelli E; Saulle R; Cruciani F; Vecchi S; Davoli M
    Epidemiol Prev; 2017; 41(5-6):279-293. PubMed ID: 29119763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabinoids for Treatment of MS Symptoms: State of the Evidence.
    Rice J; Cameron M
    Curr Neurol Neurosci Rep; 2018 Jun; 18(8):50. PubMed ID: 29923025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical marijuana patient counseling points for health care professionals based on trends in the medical uses, efficacy, and adverse effects of cannabis-based pharmaceutical drugs.
    Parmar JR; Forrest BD; Freeman RA
    Res Social Adm Pharm; 2016; 12(4):638-54. PubMed ID: 26443472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cannabis paradox.
    Ladouceur R
    Can Fam Physician; 2018 Feb; 64(2):86. PubMed ID: 29449225
    [No Abstract]   [Full Text] [Related]  

  • 6. The anti-inflammatory and analgesic effects of formulated full-spectrum cannabis extract in the treatment of neuropathic pain associated with multiple sclerosis.
    Maayah ZH; Takahara S; Ferdaoussi M; Dyck JRB
    Inflamm Res; 2020 Jun; 69(6):549-558. PubMed ID: 32239248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacokinetics, efficacy, safety, and ease of use of a novel portable metered-dose cannabis inhaler in patients with chronic neuropathic pain: a phase 1a study.
    Eisenberg E; Ogintz M; Almog S
    J Pain Palliat Care Pharmacother; 2014 Sep; 28(3):216-25. PubMed ID: 25118789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring cannabis use by patients with multiple sclerosis in a state where cannabis is legal.
    Weinkle L; Domen CH; Shelton I; Sillau S; Nair K; Alvarez E
    Mult Scler Relat Disord; 2019 Jan; 27():383-390. PubMed ID: 30502644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [There is evidence for the use of cannabinoids for symptomatic treatment of multiple sclerosis].
    Basinski H; Jensen HB; Stenager E
    Ugeskr Laeger; 2014 Mar; 176(12A):. PubMed ID: 25350886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical Cannabis for Neuropathic Pain.
    Lee G; Grovey B; Furnish T; Wallace M
    Curr Pain Headache Rep; 2018 Feb; 22(1):8. PubMed ID: 29388063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cannabinoids for neuropathic pain management].
    Andersen LØ; Enggaard TP; Højsted J
    Ugeskr Laeger; 2018 Feb; 180(9):. PubMed ID: 29506645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabis derivatives and pain. A small role for delta9-tetrahydrocannabinol (THC) in some forms of multiple sclerosis.
    Prescrire Int; 2009 Oct; 18(103):226. PubMed ID: 19882800
    [No Abstract]   [Full Text] [Related]  

  • 13. Coming off cannabis: a cognitive and magnetic resonance imaging study in patients with multiple sclerosis.
    Feinstein A; Meza C; Stefan C; Staines RW
    Brain; 2019 Sep; 142(9):2800-2812. PubMed ID: 31363742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effects of Cannabis Among Adults With Chronic Pain and an Overview of General Harms: A Systematic Review.
    Nugent SM; Morasco BJ; O'Neil ME; Freeman M; Low A; Kondo K; Elven C; Zakher B; Motu'apuaka M; Paynter R; Kansagara D
    Ann Intern Med; 2017 Sep; 167(5):319-331. PubMed ID: 28806817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabinoids in Neurologic Illnesses.
    Patel AD
    Neurol Clin; 2021 Feb; 39(1):231-241. PubMed ID: 33223086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical Marijuana for Treatment of Chronic Pain and Other Medical and Psychiatric Problems: A Clinical Review.
    Hill KP
    JAMA; 2015 Jun 23-30; 313(24):2474-83. PubMed ID: 26103031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabis and Cannabinoids for Chronic Pain.
    Romero-Sandoval EA; Kolano AL; Alvarado-Vázquez PA
    Curr Rheumatol Rep; 2017 Oct; 19(11):67. PubMed ID: 28983880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Illegal cannabis use is common among Danes with multiple sclerosis.
    Gustavsen S; Søndergaard HB; Andresen SR; Magyari M; Sørensen PS; Sellebjerg F; Oturai AB
    Mult Scler Relat Disord; 2019 Aug; 33():5-12. PubMed ID: 31129415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical cannabis for the treatment of chronic pain and other disorders: misconceptions and facts.
    Hill KP; Palastro MD
    Pol Arch Intern Med; 2017 Nov; 127(11):785-789. PubMed ID: 29067992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of Medical Cannabis in Neuropathic Chronic Pain Management.
    Bennici A; Mannucci C; Calapai F; Cardia L; Ammendolia I; Gangemi S; Calapai G; Griscti Soler D
    Molecules; 2021 Oct; 26(20):. PubMed ID: 34684842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.